Prostigmin 12,5 mg/5 mL Injektionslösung
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
neostigmini metilsulfas
Available from:
MEDA Pharmaceuticals Switzerland GmbH
ATC code:
N07AA01
INN (International Name):
neostigmini metilsulfas
Pharmaceutical form:
Injektionslösung
Composition:
neostigmini metilsulfas 12.5 mg, natrii chloridum, conserv.: phenolum 20 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Class:
B
Therapeutic group:
Synthetika
Therapeutic area:
Cholinergicum, Antimyasthenicum
Authorization status:
zugelassen
Authorization date:
1952-04-25
